Posted by Michael Wonder on 13 Mar 2019
PHARMAC funding should be doubled - breast cancer advocate
13 March 2019 - A breast cancer advocate believes PHARMAC needs to have its funding doubled to better serve New Zealanders.
Elisa Lavelle Wijohn thought she was in the clear five years after her initial diagnosis with breast cancer, but found out instead it had metastasised to her spine and hip.
But palbociclib, one of the drugs she's taking to treat it, isn't funded so her parents are shelling out $5850 a month to keep her alive.
